Skip to main navigation Skip to search Skip to main content

Transient inhibition of mTOR in human pluripotent stem cells enables robust formation of mouse-human chimeric embryos

  • Zhixing Hu
  • , Hanqin Li
  • , Houbo Jiang
  • , Yong Ren
  • , Xinyang Yu
  • , Jingxin Qiu
  • , Aimee B. Stablewski
  • , Boyang Zhang
  • , Michael J. Buck
  • , Jian Feng
  • SUNY Buffalo
  • Roswell Park Cancer Institute

Research output: Contribution to journalArticlepeer-review

56 Scopus citations

Abstract

It has not been possible to generate naïve human pluripotent stem cells (hPSCs) that substantially contribute to mouse embryos. We found that a brief inhibition of mTOR with Torin1 converted hPSCs from primed to naïve pluripotency. The naïve hPSCs were maintained in the same condition as mouse embryonic stem cells and exhibited high clonogenicity, rapid proliferation, mitochondrial respiration, X chromosome reactivation, DNA hypomethylation, and transcriptomes sharing similarities to those of human blastocysts. When transferred to mouse blastocysts, naïve hPSCs generated 0.1 to 4% human cells, of all three germ layers, including large amounts of enucleated red blood cells, suggesting a marked acceleration of hPSC development in mouse embryos. Torin1 induced nuclear translocation of TFE3; TFE3 with mutated nuclear localization signal blocked the primed-to-naïve conversion. The generation of chimera-competent naïve hPSCs unifies some common features of naïve pluripotency in mammals and may enable applications such as human organ generation in animals.

Original languageEnglish
Article numbereaaz0298
JournalScience Advances
Volume6
Issue number20
DOIs
StatePublished - May 2020

Fingerprint

Dive into the research topics of 'Transient inhibition of mTOR in human pluripotent stem cells enables robust formation of mouse-human chimeric embryos'. Together they form a unique fingerprint.

Cite this